NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Sofinnova Ventures’

23 July 2014

Sofinnova Ventures tops out Fund VIII raise at $500m hard cap

microscope7_sq Biotechnology-focused Sofinnova Ventures has held a final close of its ninth fund on its $500m hard cap, confirming an AltAssets story from mid-July.

14 July 2014

Sofinnova Ventures could raise $500m for Fund IX

biotech virus lab Biotechnology-focused Sofinnova Ventures is targeting up to $500m for a ninth fund AltAssets reported it had started to raise earlier this month.

3 July 2014

Sofinnova gets $35m MassPRIM commitment for $425m-targeting ninth fund

biotech Venture capital firm Sofinnova Ventures is reportedly seeking $425m for its new fund, data from the MassPRIM.

29 May 2014

Sofinnova leads $72.8m Series B for Spark Therapeutics

medd Venture capital firm Sofinnova has led a massive $72.8m Series B round for gene therapy specialist Spark Therapeutics.

21 May 2014

KKR joins investors in biotherapeutics developer Coherus BioSciences

Coherus BioSciences, a US biologics platform company focused on biosimilars, has closed a Series C round raising $55m from investors including KKR, Venrock, RA Capital Management, Rock Springs Capital and Fidelity Biosciences.

19 May 2014

Sorbent Therapeutics secures $6.5m

medical monitor Biopharmaceutical startup Sorbent Therapeutics, which is focused on developing therapies for cardiovascular and renal diseases, has closed a $6.5m tranche in its $15m Series D funding round.

22 April 2014

Sofinnova Ventures leads $50m Principia Biopharma Series B round

news_virus_lrg Sofinnova Ventures has helped more than double outside capital raised by Principia Biopharma by leading a $50m financing round.

11 April 2014

Sofinnova Ventures leads $57m Series C round for anti-cancer company NuCana

cancer band pink_sq Sofinnova Ventures has led a $57m Series C financing round for anti-cancer medicine developer NuCana.

24 March 2014

Venture capital-backed Versartis soars after IPO

Venture capital-backed Versartis soars after IPO

29 August 2013

Sofinnova Partners, Ventures team up to lead €25.6m ObsEva Series A

pregnant baby birth Sofinnova Partners and Sofinnova Ventures have co-led a €25.6m Series A financing round for Switzerland-based women’s reproductive drug medicine maker ObsEva.

Page 1 of 212

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014